Skip to main content
. 2017 Aug 4;40(4):1067–1077. doi: 10.3892/ijmm.2017.3091

Figure 4.

Figure 4

Equivalent baseline bone density and equivalent response to high-dose receptor activator of nuclear factor-κB ligand (RANKL) in Wt and breast cancer associated gene 3 (BCA3) transgenic mice. (A) Total and regional BMD by DXA in Wt and BCA3 transgenic mice. (B) Mean serum CTX values in Wt and BCA3 transgenic animals. (C) Calcemic response to short-term high-dose RANKL in Wt and BCA transgenic animals. Data were analyzed by an unpaired t-test (***p<0.001; NS, p>0.05). NS, not significant.